GlassScriptPhysician profile
Fitsum E Alemu
NPI 1255051306
$2,224.08
in general payments reported to CMS, 2019-2025
12 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 87% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $196 · 2024: $566 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357 · Travel and Lodging: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.48 |
| Travel and Lodging | $866.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainsway USA INC | $866.60 | 2025 | Deep Tms System |
| Abbvie INC. | $598.07 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $287.20 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $172.63 | 2023-2025 | Uzedy, Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $103.03 | 2024-2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $84.03 | 2024-2025 | Trintellix |
| Lundbeck LLC | $30.77 | 2024-2025 | Rexulti, Vyepti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.39 | 2025 | Caplyta |
| Celgene Corporation | $16.56 | 2023 | Zeposia |
| Alkermes, INC. | $15.63 | 2024 | Aristada, Lybalvi |
| Pacira Pharmaceuticals Incorporated | $15.00 | 2024 | Exparel, Iovera, Zilretta |
| Scilex Pharmaceuticals INC. | $14.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fitsum Alemu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.